Application 050672

Type
NDA
Sponsor
GLAXOSMITHKLINE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CEFTINCEFUROXIME AXETILFOR SUSPENSION;ORALEQ 125MG BASE/5MLYesNo
002CEFTINCEFUROXIME AXETILFOR SUSPENSION;ORALEQ 250MG BASE/5MLYesNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
66687SUPPL2021-03-09
66663SUPPL2021-03-09
58435SUPPL2019-04-26
50085SUPPL2017-10-18
50072SUPPL2017-10-17
45976SUPPL2016-12-01
45951SUPPL2016-11-23
30257SUPPL2015-08-28
18002SUPPL2015-08-27
30256SUPPL2015-07-07
39091SUPPL2015-07-01
30255SUPPL2014-09-23
30254SUPPL2014-09-23
39090SUPPL2014-09-22
39089SUPPL2014-09-22
39088SUPPL2007-08-02
7968SUPPL2007-08-02
39087SUPPL2004-06-07
30253SUPPL2004-06-07
30252SUPPL2002-04-11
18001SUPPL2002-04-11
18000SUPPL2002-03-29
7967SUPPL2002-03-29
30251SUPPL1999-08-24
22176SUPPL1999-08-24